113 related articles for article (PubMed ID: 12031873)
1. Synthesis and biological evaluation of technetium(III) mixed-ligand complexes with high affinity for the cerebral 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Drews A; Pietzsch HJ; Syhre R; Seifert S; Varnäs K; Hall H; Halldin C; Kraus W; Karlsson P; Johnsson C; Spies H; Johannsen B
Nucl Med Biol; 2002 May; 29(4):389-98. PubMed ID: 12031873
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
Heimbold I; Drews A; Kretzschmar M; Varnäs K; Hall H; Halldin C; Syhre R; Kraus W; Pietzsch HJ; Seifert S; Brust P; Johannsen B
Nucl Med Biol; 2002 May; 29(4):375-87. PubMed ID: 12031872
[TBL] [Abstract][Full Text] [Related]
3. A novel technetium-99m radioligand for the 5-HT(1A) receptor derived from desmethyl-WAY-100635 (DWAY).
Heimbold I; Drews A; Syhre R; Kretzschmar M; Pietzsch HJ; Johannsen B
Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):82-7. PubMed ID: 11807611
[TBL] [Abstract][Full Text] [Related]
4. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.
López-Rodríguez ML; Morcillo MJ; Fernández E; Rosado ML; Pardo L; Schaper K
J Med Chem; 2001 Jan; 44(2):198-207. PubMed ID: 11170629
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.
López-Rodríguez ML; Morcillo MJ; Fernández E; Porras E; Orensanz L; Beneytez ME; Manzanares J; Fuentes JA
J Med Chem; 2001 Jan; 44(2):186-97. PubMed ID: 11170628
[TBL] [Abstract][Full Text] [Related]
7. In vivo characterization of p-[(18)F]MPPF, a fluoro analog of WAY-100635 for visualization of 5-HT(1a) receptors.
Ginovart N; Hassoun W; Le Bars D; Weissmann D; Leviel V
Synapse; 2000 Mar; 35(3):192-200. PubMed ID: 10657026
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
McCarron JA; Zoghbi SS; Shetty HU; Vermeulen ES; Wikström HV; Ichise M; Yasuno F; Halldin C; Innis RB; Pike VW
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
[TBL] [Abstract][Full Text] [Related]
9. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ
Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431
[TBL] [Abstract][Full Text] [Related]
10. (11)C-CUMI-101, a PET radioligand, behaves as a serotonin 1A receptor antagonist and also binds to α(1) adrenoceptors in brain.
Shrestha SS; Liow JS; Lu S; Jenko K; Gladding RL; Svenningsson P; Morse CL; Zoghbi SS; Pike VW; Innis RB
J Nucl Med; 2014 Jan; 55(1):141-6. PubMed ID: 24385311
[TBL] [Abstract][Full Text] [Related]
11. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
Perrone R; Berardi F; Colabufo NA; Leopoldo M; Lacivita E; Tortorella V; Leonardi A; Poggesi E; Testa R
J Med Chem; 2001 Dec; 44(25):4431-42. PubMed ID: 11728188
[TBL] [Abstract][Full Text] [Related]
12. Oxotechnetium 99mTcO[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Tsoukalas Ch; Nikoladou L; Drossopoulou G; Dalla C; Pelecanou M; Papadopoulou-Daifotis Z; Papadopoulos M; Chiotellis E
Nucl Med Biol; 2002 Nov; 29(8):825-32. PubMed ID: 12453592
[TBL] [Abstract][Full Text] [Related]
13. Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats.
Plenevaux A; Weissmann D; Aerts J; Lemaire C; Brihaye C; Degueldre C; Le Bars D; Comar D; Pujol J; Luxen A
J Neurochem; 2000 Aug; 75(2):803-11. PubMed ID: 10899958
[TBL] [Abstract][Full Text] [Related]
14. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of 4-[123I]iodo-N-[2[4-(6-trifluoromethyl-2-pyridinyl)-1-piperazinyl]ethyl]benzamide, a potential SPECT radioligand for the 5-HT1A receptor.
Vandecapelle M; De Vos F; Vermeirsch H; De Ley G; Audenaert K; Leysen D; Dierckx RA; Slegers G
Nucl Med Biol; 2001 Aug; 28(6):639-43. PubMed ID: 11518645
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and autoradiographic evaluation of a novel high-affinity Tc-99m ligand for the 5-HT2A receptor.
Pietzsch HJ; Scheunemann M; Kretzschmar M; Elz S; Pertz HH; Seifert S; Brust P; Spies H; Syhre R; Johannsen B
Nucl Med Biol; 1999 Nov; 26(8):865-75. PubMed ID: 10708299
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
Meller E; Li H; Carr KD; Hiller JM
J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
[TBL] [Abstract][Full Text] [Related]
18. Affinity of (+/-)-pindolol, (-)-penbutolol, and (-)-tertatolol for pre- and postsynaptic serotonin 5-HT(1A) receptors in human and rat brain.
Castro ME; Harrison PJ; Pazos A; Sharp T
J Neurochem; 2000 Aug; 75(2):755-62. PubMed ID: 10899952
[TBL] [Abstract][Full Text] [Related]
19.
Vidal B; Fieux S; Colom M; Billard T; Bouillot C; Barret O; Constantinescu C; Tamagnan G; Newman-Tancredi A; Zimmer L
Brain Struct Funct; 2018 Jul; 223(6):2973-2988. PubMed ID: 29730825
[TBL] [Abstract][Full Text] [Related]
20. Development of novel mixed-ligand oxotechnetium [SNS/S] complexes as potential 5-HT1A receptor imaging agents.
Papagiannopoulou D; Pirmettis I; Maina T; Pelecanou M; Nikolopoulou A; Chiotellis E; Raptopoulou CP; Vlahos AT; Terzis A; Papadopoulos M; Chiotellis E
J Biol Inorg Chem; 2001 Mar; 6(3):256-65. PubMed ID: 11315561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
